 | FGA | Name: | GAMMA-D-GLUTAMIC ACID | Formula: | C5 H9 N O4 | SMILES: | O=C(O)C(N)CCC(=O)O | InChi: | InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m1/s1 | Synonyms: | D-GLUTAMIC ACID | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | D-glutamic acid |
|
 | FGF | Name: | N-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-7-methanoyl-6-[(4-methyl-2-oxidanylidene-piperazin-1-yl)methyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | Formula: | C25 H30 N8 O4 | SMILES: | COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc23)ncc1C#N | InChi: | InChI=1S/C25H30N8O4/c1-31-7-8-32(23(35)15-31)14-18-10-17-4-3-6-33(24(17)29-21(18)16-34)25(36)30-22-11-20(27-5-9-37-2)19(12-26)13-28-22/h10-11,13,16H,3-9,14-15H2,1-2H3,(H2,27,28,30,36) | Synonyms: | Roblitinib | Definition date: | 2019-04-02 | Last modified: | 2024-09-27 | Release date: | 2019-05-15 | Identifier: | ~{N}-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-7-methanoyl-6-[(4-methyl-2-oxidanylidene-piperazin-1-yl)methyl]-3,4-dihydro-2~{H}-1,8-naphthyridine-1-carboxamide |
|
 | FGP | Name: | 2-AMINO-3-HYDROXY-3-PHOSPHONOOXY-PROPIONIC ACID | Formula: | C3 H8 N O7 P | SMILES: | O=P(OC(O)C(N)C(=O)O)(O)O | InChi: | InChI=1S/C3H8NO7P/c4-1(2(5)6)3(7)11-12(8,9)10/h1,3,7H,4H2,(H,5,6)(H2,8,9,10)/t1-,3+/m1/s1 | Definition date: | 2002-10-28 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-(phosphonooxy)-L-serine |
|
 | BHD | Name: | (3S)-3-hydroxy-L-aspartic acid | Formula: | C4 H7 N O5 | SMILES: | O=C(O)C(O)C(C(=O)O)N | InChi: | InChI=1S/C4H7NO5/c5-1(3(7)8)2(6)4(9)10/h1-2,6H,5H2,(H,7,8)(H,9,10)/t1-,2-/m0/s1 | Synonyms: | BETA-HYDROXYASPARTIC ACID | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-hydroxy-L-aspartic acid |
|
 | BHI | Name: | 4-BROMO-3-HYDROXY-3-METHYL BUTYL DIPHOSPHATE | Formula: | C5 H13 Br O8 P2 | SMILES: | O=P(OP(=O)(OCCC(O)(C)CBr)O)(O)O | InChi: | InChI=1S/C5H13BrO8P2/c1-5(7,4-6)2-3-13-16(11,12)14-15(8,9)10/h7H,2-4H2,1H3,(H,11,12)(H2,8,9,10)/t5-/m1/s1 | Definition date: | 2002-11-12 | Last modified: | 2024-09-27 | Identifier: | (3R)-4-bromo-3-hydroxy-3-methylbutyl trihydrogen diphosphate |
|
 | BIF | Name: | (R)-2-AMINO-3-(4-PHENYLCYCLOHEXYL)PROPANOIC ACID | Formula: | C15 H15 N O2 | SMILES: | O=C(O)C(N)Cc1ccc(cc1)c2ccccc2 | InChi: | InChI=1S/C15H15NO2/c16-14(15(17)18)10-11-6-8-13(9-7-11)12-4-2-1-3-5-12/h1-9,14H,10,16H2,(H,17,18)/t14-/m0/s1 | Synonyms: | BIPHENYLALANINE | Definition date: | 2005-03-29 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-amino-3-biphenyl-4-ylpropanoic acid (non-preferred name) |
|
 | BIL | Name: | (3R,4S)-3-amino-4-methylhexanoic acid | Formula: | C7 H15 N O2 | SMILES: | O=C(O)CC(N)C(CC)C | InChi: | InChI=1S/C7H15NO2/c1-3-5(2)6(8)4-7(9)10/h5-6H,3-4,8H2,1-2H3,(H,9,10)/t5-,6+/m0/s1 | Synonyms: | (R,S)-beta-3-homoisoleucine | Definition date: | 2008-02-05 | Last modified: | 2024-09-27 | Identifier: | (3R,4S)-3-amino-4-methylhexanoic acid |
|
 | BIP | Name: | 2-BENZYL-3-IODOPROPANOIC ACID | Formula: | C10 H11 I O2 | SMILES: | O=C(O)C(CI)Cc1ccccc1 | InChi: | InChI=1S/C10H11IO2/c11-7-9(10(12)13)6-8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,12,13)/t9-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (2R)-2-benzyl-3-iodopropanoic acid |
|
 | BIU | Name: | 5-bromo-L-isoleucine | Formula: | C6 H12 Br N O2 | SMILES: | BrCCC(C(N)C(=O)O)C | InChi: | InChI=1S/C6H12BrNO2/c1-4(2-3-7)5(8)6(9)10/h4-5H,2-3,8H2,1H3,(H,9,10)/t4-,5-/m0/s1 | Definition date: | 2008-09-08 | Last modified: | 2024-09-27 | Identifier: | 5-bromo-L-isoleucine |
|
 | BIX | Name: | (2S)-2-{[(S)-[(3S)-3-amino-3-carboxypropyl](hydroxy)phosphoryl]methyl}pentanedioic acid | Formula: | C10 H18 N O8 P | SMILES: | O=C(O)CCC(C(=O)O)CP(=O)(O)CCC(C(=O)O)N | InChi: | InChI=1S/C10H18NO8P/c11-7(10(16)17)3-4-20(18,19)5-6(9(14)15)1-2-8(12)13/h6-7H,1-5,11H2,(H,12,13)(H,14,15)(H,16,17)(H,18,19)/t6-,7+/m1/s1 | Definition date: | 2007-11-30 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-{[(S)-[(3S)-3-amino-3-carboxypropyl](hydroxy)phosphoryl]methyl}pentanedioic acid |
|
 | BIY | Name: | (3S)-2,2-dimethyl-3,4-dihydro-2H-1,4-thiazine-3,6-dicarboxylic acid | Formula: | C8 H11 N O4 S | SMILES: | O=C(O)C=1SC(C)(C)C(C(=O)O)NC=1 | InChi: | InChI=1S/C8H11NO4S/c1-8(2)5(7(12)13)9-3-4(14-8)6(10)11/h3,5,9H,1-2H3,(H,10,11)(H,12,13)/t5-/m0/s1 | Definition date: | 2009-06-04 | Last modified: | 2024-09-27 | Identifier: | (3S)-2,2-dimethyl-3,4-dihydro-2H-1,4-thiazine-3,6-dicarboxylic acid |
|
 | BJF | Name: | {2-[(1S)-1-amino-3-methylbutyl]-5-hydroxy-4-(2-methylpropyl)-1H-imidazol-1-yl}acetic acid | Formula: | C14 H25 N3 O3 | SMILES: | Oc1c(CC(C)C)nc(C(N)CC(C)C)n1CC(O)=O | InChi: | InChI=1S/C14H25N3O3/c1-8(2)5-10(15)13-16-11(6-9(3)4)14(20)17(13)7-12(18)19/h8-10,20H,5-7,15H2,1-4H3,(H,18,19)/t10-/m0/s1 | Synonyms: | CHROMOPHORE (LEU-LEU-GLY) | Definition date: | 2019-02-06 | Last modified: | 2024-09-27 | Release date: | 2019-03-20 | Identifier: | {2-[(1S)-1-amino-3-methylbutyl]-5-hydroxy-4-(2-methylpropyl)-1H-imidazol-1-yl}acetic acid |
|
 | BJH | Name: | 1(R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID | Formula: | C11 H14 B N O6 | SMILES: | O=C(O)c1cccc(c1O)CC(B(O)O)NC(=O)C | InChi: | InChI=1S/C11H14BNO6/c1-6(14)13-9(12(18)19)5-7-3-2-4-8(10(7)15)11(16)17/h2-4,9,15,18-19H,5H2,1H3,(H,13,14)(H,16,17)/t9-/m0/s1 | Definition date: | 2000-04-20 | Last modified: | 2024-09-27 | Identifier: | 3-[(2R)-2-(acetylamino)-2-(dihydroxyboranyl)ethyl]-2-hydroxybenzoic acid |
|
 | BJI | Name: | 1(R)-1-ACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID | Formula: | C11 H14 B N O5 | SMILES: | O=C(O)c1cc(ccc1)CC(NC(=O)C)B(O)O | InChi: | InChI=1S/C11H14BNO5/c1-7(14)13-10(12(17)18)6-8-3-2-4-9(5-8)11(15)16/h2-5,10,17-18H,6H2,1H3,(H,13,14)(H,15,16)/t10-/m0/s1 | Definition date: | 2000-04-17 | Last modified: | 2024-09-27 | Identifier: | 3-[(2R)-2-(acetylamino)-2-(dihydroxyboranyl)ethyl]benzoic acid |
|
 | BJM | Name: | (2~{S})-2-azanyl-1-[(1~{S},3~{S},5~{S})-3-(iminomethyl)-2-azabicyclo[3.1.0]hexan-2-yl]-2-[(5~{R},7~{S})-3-oxidanyl-1-ad
amantyl]ethanone | Formula: | C18 H27 N3 O2 | SMILES: | N[CH](C(=O)N1[CH](C[CH]2C[CH]12)C=N)C34C[CH]5C[CH](CC(O)(C5)C3)C4 | InChi: | InChI=1S/C18H27N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h8,10-15,19,23H,1-7,9,20H2/t10-,11+,12-,13+,14+,15-,17+,18-/m1/s1 | Synonyms: | Saxagliptin, bound form | Definition date: | 2007-12-13 | Last modified: | 2024-09-27 | Identifier: | (2~{S})-2-azanyl-1-[(1~{S},3~{S},5~{S})-3-(iminomethyl)-2-azabicyclo[3.1.0]hexan-2-yl]-2-[(5~{R},7~{S})-3-oxidanyl-1-adamantyl]ethanone |
|
 | BJO | Name: | (4Z)-4-amino-4-{1-(carboxymethyl)-5-oxo-4-[(4-oxocyclohexa-2,5-dien-1-ylidene)methyl]-1,5-dihydro-2H-imidazol-2-ylidene}butanoic acid | Formula: | C16 H15 N3 O6 | SMILES: | O=C(CCC(=C2/N=C(C=C1/C=CC(C=C1)=O)C(=O)N2CC(=O)O)N)O | InChi: | InChI=1S/C16H15N3O6/c17-11(5-6-13(21)22)15-18-12(16(25)19(15)8-14(23)24)7-9-1-3-10(20)4-2-9/h1-4,7H,5-6,8,17H2,(H,21,22)(H,23,24)/b15-11- | Synonyms: | CHROMOPHORE (GLU-TYR-GLY) | Definition date: | 2019-02-07 | Last modified: | 2024-09-27 | Release date: | 2019-03-20 | Identifier: | (4Z)-4-amino-4-{1-(carboxymethyl)-5-oxo-4-[(4-oxocyclohexa-2,5-dien-1-ylidene)methyl]-1,5-dihydro-2H-imidazol-2-ylidene}butanoic acid |
|
 | BJP | Name: | (1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID | Formula: | C17 H18 B N O5 | SMILES: | O=C(O)c1cc(ccc1)CC(NC(=O)Cc2ccccc2)B(O)O | InChi: | InChI=1S/C17H18BNO5/c20-16(11-12-5-2-1-3-6-12)19-15(18(23)24)10-13-7-4-8-14(9-13)17(21)22/h1-9,15,23-24H,10-11H2,(H,19,20)(H,21,22)/t15-/m0/s1 | Definition date: | 2000-04-19 | Last modified: | 2024-09-27 | Identifier: | 3-{(2R)-2-(dihydroxyboranyl)-2-[(phenylacetyl)amino]ethyl}benzoic acid |
|
 | BKM | Name: | (2Z)-2-[(1R)-3-{[(2R,3S,4R,7S,8S,11S,13R,16E)-17-ethyl-4,8-dihydroxy-3,7,11,13-tetramethyl-6,15-dioxononadeca-16,18-dien-2-yl]oxy}-1-hydroxy-3-oxopropyl]-3-methylbut-2-enedioic acid | Formula: | C33 H52 O11 | SMILES: | C=[C@H]C(=[C@H]C(CC(CC(C)CCC(C(C)C(CC(O)C(C)C(C)OC(=O)CC(/C(C(O)=O)=C(/C(=O)O)C)O)=O)O)C)=O)CC | InChi: | InChI=1S/C33H52O11/c1-9-24(10-2)15-25(34)14-19(4)13-18(3)11-12-26(35)21(6)28(37)16-27(36)20(5)23(8)44-30(39)17-29(38)31(33(42)43)22(7)32(40)41/h9,15,18-21,23,26-27,29,35-36,38H,1,10-14,16-17H2,2-8H3,(H,40,41)(H,42,43)/b24-15-,31-22-/t18-,19+,20+,21-,23+,26-,27+,29+/m0/s1 | Synonyms: | Tautomycetin diacid form | Definition date: | 2017-08-10 | Last modified: | 2024-09-27 | Release date: | 2017-11-29 | Identifier: | (2Z)-2-[(1R)-3-{[(2R,3S,4R,7S,8S,11S,13R,16E)-17-ethyl-4,8-dihydroxy-3,7,11,13-tetramethyl-6,15-dioxononadeca-16,18-dien-2-yl]oxy}-1-hydroxy-3-oxopropyl]-3-methylbut-2-enedioic acid |
|
 | BL2 | Name: | N-(tert-butoxycarbonyl)-L-leucine | Formula: | C11 H21 N O4 | SMILES: | O=C(OC(C)(C)C)NC(C(=O)O)CC(C)C | InChi: | InChI=1S/C11H21NO4/c1-7(2)6-8(9(13)14)12-10(15)16-11(3,4)5/h7-8H,6H2,1-5H3,(H,12,15)(H,13,14)/t8-/m0/s1 | Definition date: | 2012-05-31 | Last modified: | 2024-09-27 | Release date: | 2013-05-22 | Identifier: | N-(tert-butoxycarbonyl)-L-leucine |
|
 | BL8 | Name: | 3-[2-[(Z)-[5-[(Z)-[(3R,4R)-3-ethenyl-4-methyl-5-oxidanylidene-pyrrolidin-2-ylidene]methyl]-3-(3-hydroxy-3-oxopropyl)-4-methyl-pyrrol-2-ylidene]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid | Formula: | C33 H36 N4 O6 | SMILES: | C[CH]1[CH](C=C)C(NC1=O)=CC2=NC(=Cc3[nH]c(C=C4NC(=O)C(=C4C)C=C)c(C)c3CCC(O)=O)C(=C2C)CCC(O)=O | InChi: | InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-15,19-20,34H,1-2,9-12H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-,29-15-/t19-,20-/m1/s1 | Definition date: | 2015-03-16 | Last modified: | 2024-09-27 | Release date: | 2015-12-09 | Identifier: | 3-[2-[(Z)-[5-[(Z)-[(3R,4R)-3-ethenyl-4-methyl-5-oxidanylidene-pyrrolidin-2-ylidene]methyl]-3-(3-hydroxy-3-oxopropyl)-4-methyl-pyrrol-2-ylidene]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid |
|
 | BLA | Name: | BILIVERDINE IX ALPHA | Formula: | C33 H34 N4 O6 | SMILES: | Cc1c([nH]c(C=C2N=C(C=C3NC(=O)C(=C3C=C)C)C(=C2CCC(O)=O)C)c1CCC(O)=O)C=C4NC(=O)C(=C4C)C=C | InChi: | InChI=1S/C33H34N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-15,34H,1-2,9-12H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-,29-15- | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 3-{2-((Z)-{3-(2-carboxyethyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-2H-pyrrol-2-ylidene}methyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid |
|
 | BLE | Name: | LEUCINE BORONIC ACID | Formula: | C5 H14 B N O2 | SMILES: | OB(O)C(N)CC(C)C | InChi: | InChI=1S/C5H14BNO2/c1-4(2)3-5(7)6(8)9/h4-5,8-9H,3,7H2,1-2H3/t5-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | [(1R)-1-amino-3-methylbutyl]boronic acid |
|
 | BLN | Name: | MORPHOLINE-4-CARBOXYLIC ACID [1S-(2-BENZYLOXY-1R-CYANO-ETHYLCARBAMOYL)-3-METHYL-BUTYL]AMIDE | Formula: | C21 H30 N4 O4 | SMILES: | O=C(NC(C(=O)NC(C#N)COCc1ccccc1)CC(C)C)N2CCOCC2 | InChi: | InChI=1S/C21H30N4O4/c1-16(2)12-19(24-21(27)25-8-10-28-11-9-25)20(26)23-18(13-22)15-29-14-17-6-4-3-5-7-17/h3-7,16,18-19H,8-12,14-15H2,1-2H3,(H,23,26)(H,24,27)/t18-,19+/m1/s1 | Definition date: | 2002-10-04 | Last modified: | 2024-09-27 | Identifier: | N-[(1R)-2-(benzyloxy)-1-cyanoethyl]-N~2~-(morpholin-4-ylcarbonyl)-L-leucinamide |
|
 | BLR | Name: | 3-[5-[(Z)-(4-ethenyl-3-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-2-[[5-[(Z)-(3-ethenyl-4-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-3-(3-hydroxy-3-oxopropyl)-4-methyl-1H-pyrrol-2-yl]methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid | Formula: | C33 H36 N4 O6 | SMILES: | CC1=C(C=C)C(NC1=O)=Cc2[nH]c(Cc3[nH]c(C=C4NC(=O)C(=C4C)C=C)c(C)c3CCC(O)=O)c(CCC(O)=O)c2C | InChi: | InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14- | Synonyms: | Bilirubin IX alpha | Definition date: | 2015-01-26 | Last modified: | 2024-09-27 | Release date: | 2015-02-04 | Identifier: | 3-[5-[(Z)-(4-ethenyl-3-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-2-[[5-[(Z)-(3-ethenyl-4-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-3-(3-hydroxy-3-oxopropyl)-4-methyl-1H-pyrrol-2-yl]methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid |
|
 | BMA | Name: | beta-D-mannopyranose | Formula: | C6 H12 O6 | SMILES: | OC1C(O)C(OC(O)C1O)CO | InChi: | InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5+,6-/m1/s1 | Synonyms: | beta-D-mannose | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | beta-D-mannopyranose |
|